Why the study?
Advances in genetics are improving the understanding of inherited cardiovascular diseases, but not all cardiovascular practitioners are fully aware of the utility and pitfalls of incorporating genetic testing into patient care.
Key points are not available for this paper at this time.
Design
American Heart Association scientific statement
Answers are grounded in this paper and cite their sources.
Genetic testing guidance remains underutilized due to practitioner gaps; leaves open optimal implementation and outcome impact in inherited CVD.
Advances in human genetics are improving the understanding of a variety of inherited cardiovascular diseases, including cardiomyopathies, arrhythmic disorders, vascular disorders, and lipid disorders such as familial hypercholesterolemia. However, not all cardiovascular practitioners are fully aware of the utility and potential pitfalls of incorporating genetic test results into the care of patients and their families. This statement summarizes current best practices with respect to genetic testing and its implications for the management of inherited cardiovascular diseases.
No takes yet. Share an insight, caveat, or question.
Musunuru et al. (2020) studied this question. Genetic testing enhances understanding and management of inherited cardiovascular diseases, yet many practitioners remain unaware of its utility and limitations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: